Skip to content

4Accepted Oct 8, 9:50 PM ET

TRex Bio: director Peter Hirth received 17,500 shares

TRXBTRex Bio, Inc.

Accepted (ET)

9:50 PM

Oct 8, 2026

Filed

Oct 8, 2026

Documents

1

Size

5.3 KB

Summary

TRex Bio: director Peter Hirth received 17,500 shares

Updated

What happened

  • Peter Hirth, a director, received a grant (transaction code A) of 17,500 shares as a derivative on Oct 8, 2026. The filing shows a price of $0.00 and a total value of $0.00.

Key details

  • Transaction date and price: Oct 8, 2026 at $0.00 per share (transaction code A: award/grant/acquisition).
  • Shares owned after the transaction: not reported in this filing.
  • Relevant footnote: "The option vests in full on Oct 8, 2027, subject to the reporting person's continued service through such date." (footnote F1)
  • Filing date: filed on Oct 8, 2026 (as shown on the Form 4).

Why it may matter

  • This was a derivative award that vests in full on Oct 8, 2027, subject to continued service; it was not an immediate market sale or purchase.
  • A filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing